- Q4 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 07, 2024₪4.01 (+1.47%)Earnings
- Q3 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 09, 2023₪4.29 (-0.81%)Earnings
- Q2 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 10, 2023₪5.4 (+3.15%)Earnings
- Q1 2023 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 11, 2023₪5.25 (-2.83%)Earnings
- Q4 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 09, 2023₪5.18 (+2.55%)Earnings
- Q3 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 10, 2022₪4.48 (+1.93%)Earnings
- Q2 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 11, 2022₪5.11 (+2.98%)Earnings
- Q1 2022 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 12, 2022₪4.13 (-2.32%)Earnings
- Lineage Cell Therapeutics Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 27, 2022
- Lineage Cell Therapeutics Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 20, 2022
- Q4 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 10, 2022₪4.57 (+6.24%)Earnings
- Lineage Cell Therapeutics Inc To Discuss Worldwide OpRegen Collaboration Call TranscriptDec 20, 2021
- Q3 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 10, 2021₪7.74 (-0.55%)Earnings
- Lineage Cell Therapeutics Inc at B Riley Fall Growth Biotech Best Ideas (Virtual) TranscriptOct 18, 2021
- Q2 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 12, 2021₪8.52 (-0.70%)Earnings
- Lineage Cell Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- Lineage Cell Therapeutics Inc Webinar Featuring External Therapeutic Area Experts TranscriptJun 10, 2021
- Q1 2021 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 13, 2021₪7.79 (+0.14%)Earnings
- Q4 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 11, 2021₪7.43 (-3.58%)Earnings
- Lineage Cell Therapeutics Inc Corporate Analyst Meeting TranscriptFeb 22, 2021
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptNov 17, 2020
- Q3 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 04, 2020₪4.16 (+5.32%)Earnings
- Q2 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptAug 06, 2020₪3.24 (+9.09%)Earnings
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptJun 08, 2020
- Lineage Cell Therapeutics, Inc. - Special Call TranscriptMay 11, 2020
- Q1 2020 Lineage Cell Therapeutics Inc Earnings Call TranscriptMay 07, 2020₪3.66 (+14.02%)Earnings
- Q4 2019 Lineage Cell Therapeutics Inc Earnings Call TranscriptMar 12, 2020₪2.74 (-6.48%)Earnings
- Lineage Cell Therapeutics Inc at Solebury Trout KOL Day TranscriptNov 15, 2019
- Q3 2019 Lineage Cell Therapeutics Inc Earnings Call TranscriptNov 12, 2019₪2.55 (-12.67%)Earnings
- Q2 2019 BioTime Inc Earnings Call TranscriptAug 08, 2019₪3.49 (+2.05%)Earnings
- Q1 2019 BioTime Inc Earnings Call TranscriptMay 09, 2019₪4.46Earnings
- Q4 2018 BioTime Inc Earnings Call TranscriptMar 14, 2019₪5.93 (+7.23%)Earnings
Lineage Cell Therapeutics Inc Webinar Featuring External Therapeutic Area Experts Transcript
Good afternoon, everyone. My name is Brian Culley. I'm the Chief Executive Officer of Lineage Cell Therapeutics. I'd like to welcome you to a very special webinar today.
Before I begin, I'll refer you all to our safe harbor clause as I or other Lineage executives may make some forward-looking statements today, and you can learn more about our risk factors through our filings with the Securities and Exchange Commission at sec.gov.
Now I know many of you were expecting us to report our 6-month interim data for OpRegen, but we've moved that update to next month in order to make room for something far more exciting. As you all know, we have reported that an earlier observation of retinal tissue restoration has been repeated in 2 additional patients on the OpRegen clinical trial. So we believe this is much more than just an exciting clinical observation for these 3 individuals. We believe this first-of-its-kind data using a replace-and-restore approach represents a new paradigm for how the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)